Cost-Effectiveness of Ruxolitinib for The Treatment of Myelofibrosis In Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2446
https://www.valueinhealthjournal.com/article/S1098-3015(15)04522-2/fulltext
Title : Cost-Effectiveness of Ruxolitinib for The Treatment of Myelofibrosis In Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04522-2&doi=10.1016/j.jval.2015.09.2446
First page : A669
Section Title : Research Podium Presentations - Session 1 and Session 2
Open access? : No
Section Order : 1854
Categories :
Tags :
Regions :
ViH Article Tags :